Rare diseases
Investigational molecules
Locations
Calle De Sabino Arana Num. 5, 08028 Barcelona, Spain
Research activity in cutaneous basal cell carcinoma is centered on neoadjuvant immunotherapy for high-risk, potentially resectable disease, with interest in combinations involving cemiplimab, imiquimod, and fractional laser therapy.
The sponsor’s work in this area reflects a focus on non-melanoma skin cancer management and treatment strategies aimed at improving local disease control before surgery.
Instituto Oncologico Dr. Rosell S.L. runs clinical trials in conditions such as Basal cell carcinoma, Lung neoplasm malignant, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SpainSpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
